Zhaohua Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zhaohua Li has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Changsheng Yan
Department of Gastroenterology Zhongshan Hospital Xiamen University Xiamen, Fujian China
1 shared publicationChuanxing Xiao
Department of Gastroenterology Zhongshan Hospital Xiamen University Xiamen, Fujian China
1 shared publicationDajun Chen
Department of Gastroenterology People's Hospital of Quzhou Quzhou, Zhejiang China
1 shared publication- Hongzhi Xu
Engineering Technology Research Institute of China National Petroleum Corporation, Binhai District, Tianjin, China 300451
1 shared publication Qingwen Huang
Department of Gastroenterology Zhongshan Hospital Xiamen University Xiamen, Fujian China
1 shared publicationYanyun Fan
Department of Gastroenterology Zhongshan Hospital Xiamen University Xiamen, Fujian China
1 shared publication
Latest Publications
- 5 January 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 119 (4) , 3671-3682
Knockdown of pseudogene derived from lncRNA DUXAP10 inhibits cell proliferation, migration, invasion, and promotes apoptosis in pancreatic cancer
Current evidence suggests that pseudogene derived lncRNAs may be important players in human cancer progression. Our previous study showed that DUXAP10 could promote cell proliferation in colorectal cancer. However, the clinical significance and potential role of DUXAP10 in human pancreatic cancer (PC) has not been uncovered. In this study, we found that DUXAP10 was overexpressed in PC tissues compared with normal tissues. DUXAP10 expression was significantly higher in patients with an advanced TNM stage and positive lymph node metastasis. Bioinformatic analysis showed that cell cycle progression was increased in patients with high DUXAP10 expression. In vitro and in vivo assays of DUXAP10 alterations revealed a complex integrated phenotype affecting cell growth, apoptosis, migration, and invasion. Mechanistic studies revealed that DUXAP10 has a crucial role in G2/M arrest. We further showed that DUXAP10 regulated PC cell proliferation through interact with RNA‐binding protein EZH2 and LSD1. Overall, our findings indicates that DUXAP10 is an oncogenic lncRNA that promotes PC proliferation and metastasis.
- 5 January 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 119 (4) , 3671-3682
Knockdown of pseudogene derived from lncRNA DUXAP10 inhibits cell proliferation, migration, invasion, and promotes apoptosis in pancreatic cancer
Current evidence suggests that pseudogene derived lncRNAs may be important players in human cancer progression. Our previous study showed that DUXAP10 could promote cell proliferation in colorectal cancer. However, the clinical significance and potential role of DUXAP10 in human pancreatic cancer (PC) has not been uncovered. In this study, we found that DUXAP10 was overexpressed in PC tissues compared with normal tissues. DUXAP10 expression was significantly higher in patients with an advanced TNM stage and positive lymph node metastasis. Bioinformatic analysis showed that cell cycle progression was increased in patients with high DUXAP10 expression. In vitro and in vivo assays of DUXAP10 alterations revealed a complex integrated phenotype affecting cell growth, apoptosis, migration, and invasion. Mechanistic studies revealed that DUXAP10 has a crucial role in G2/M arrest. We further showed that DUXAP10 regulated PC cell proliferation through interact with RNA‐binding protein EZH2 and LSD1. Overall, our findings indicates that DUXAP10 is an oncogenic lncRNA that promotes PC proliferation and metastasis.